ERC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Endocrine-Related Cancer 15 (2) 597 -607     DOI: 10.1677/ERC-07-0266
Copyright © 2008 by the Society for Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, X.
Right arrow Articles by Tong, P. C Y
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, X.
Right arrow Articles by Tong, P. C Y

Predicting values of lipids and white blood cell count for all-site cancer in type 2 diabetes

Xilin Yang1,*, Wing-Yee So1,*, Ronald C W Ma1, Gary T C Ko 2, Alice P S Kong1,3, Qingsheng Wang4, Clive S Cockram1, Chun-Chung Chow1, Juliana C N Chan1,2,3 and Peter C Y Tong1

1 Department of Medicine and Therapeutics2 Hong Kong Institute of Diabetes and Obesity3 Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong SAR, China4 Tianjin Cancer Hospital and Institute, Tianjin, China

(Correspondence should be addressed to J C N Chan; Email: jchan{at}cuhk.edu.hk)

Type 2 diabetic patients have increased cancer risk. We developed and validated an all-site cancer risk score in a prospective cohort of 7374 Chinese type 2 diabetic patients free of known history of cancer at enrolment, using split-half validation. Spline Cox model was used to detect common risk factors of cancer and to guide linear transformation of non-linear risk factors. After a median follow-up period of 5.45 years, 365 patients (4.95%) developed cancer. Body mass index (BMI; <24.0 or ≥27.6 kg/m2), triglyceride (≥0.81 to <1.41 mmol/l), high-density lipoprotein cholesterol (<0.9 or ≥1.8 mmol/l), total cholesterol (<4.3 mmol/l) and white blood cell (WBC) count (<5.8x109 count per litre) were associated with increased cancer risks and exhibited non-linear relationships. We further linear transformed these terms for selection using backward Cox regression (P<0.05 for stay) in the training dataset. In the test dataset, calibration was checked using Hosmer–Lemeshow test and discrimination checked using area under receiver operating characteristic curve. In addition to age and current smoking, only linear-transformed total cholesterol and WBC count were selected. The risk score was 0.0488xage (years)–0.5810xtotal cholesterol (mmol/l, coded to 4.3 if >4.3)–0.3596xWBC count (109 counts/l, 5.8 if >5.8)+0.6390xcurrent smoking status (1 if yes). The 5-year probability of cancer was 1–0.9590EXP(0.9382x(RISK SCORE+1.5903)).The predicted cancer probability was not significantly different from the observed cancer probability during the 5-year follow-up. The adjusted area under receiver operating characteristic curve was 0.712. In conclusion, BMI, lipids and WBC count have predicting values for cancer.




This article has been cited by other articles:


Home page
Diabetes CareHome page
X. Yang, W. Y. So, R. C.W. Ma, G. T.C. Ko, A. P.S. Kong, H. Zhao, A. O.Y. Luk, C. W.K. Lam, C. S. Ho, P. C.Y. Tong, et al.
Low LDL Cholesterol, Albuminuria, and Statins for the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry
Diabetes Care, October 1, 2009; 32(10): 1826 - 1832.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
X. Yang, H. Zhao, Y. Sui, R. C.W. Ma, W. Y. So, G. T.C. Ko, A. P.S. Kong, R. Ozaki, C. Y. Yeung, G. Xu, et al.
Additive Interaction Between the Renin-Angiotensin System and Lipid Metabolism for Cancer in Type 2 Diabetes
Diabetes, July 1, 2009; 58(7): 1518 - 1525.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society for Endocrinology.